MedComm Introduction

2020-02-28

Open the phone and scan



Introduction of MedComm

 

Editors-in-Chief

Prof. James Henderson Naismith 

Prof. Günter P. Wagner

Prof. Yuquan Wei


 

Profile

Profile MedComm is a peer-reviewed, online open access (OA) journal. The journal publishes a wide variety of works that provide novel insights into all aspects of medicine on the basis of novelty, timeliness and significance to human health. Original works can enjoy "fast track" mode for publication, which can be as soon as one week, and publication fee is waived for works submitted from 2020 to 2022. MedComm sincerely welcome all quality works from scientific researchers, doctors, and graduate students in the field of biomedicine.


Editors-in-Chief

James Henderson Naismith

Prof. Naismith obtained his B.S. and Ph.D. degrees from University of Edinburgh and University of Manchester (UK), respectively. After finishing his postdoctoral training at the University of Texas Southwestern Medical Center (USA), Dr. Naismith became a faculty member at University of St Andrews (UK). Currently, Dr. Naismith is the professor and Director of the Research Complex at Harwell, and the director of Rosalind Franklin Institute, University of Oxford. He has published nearly 300 papers on international journals including Nature, Nat Struct Mol Biol, Nat Commun, Nucleic Acids Res and PNAS. Renowned for his investigations of protein structure by X-ray crystallography and targeted therapy by small molecules, Dr. Naismith is elected as a fellow of the Royal Society (UK), the Academy of Medical Sciences (UK), the Royal Society of Edinburgh, the Royal Society of Chemistry and the Royal Society of Biology (UK).




Günter P. Wagner

Günter P. Wagner is a pioneer of the field of evolutionary developmental biology. His research interest is the evolution of gene regulation, evolutionary medicine, obstetrics, and reproductive sciences. Prof. Wagner spent many years at the Max Planck Institutes for Biophysical Chemistry and Developmental Biology (Germany), and Department of Zoology, U. Vienna (Austria). Currently, he is the professor of Department of Ecology and Evolutionary Biology at Yale University, and the professor of Department of Obstetrics, Gynecology and Reproductive Sciences at Yale Medical School. Prof. Wagner has published around 200 academic papers in famous journals, including Nature, Nature Genetics, Genome Research, Nature Review, NEJM, Science, PNAS and so on. Prof. Wagner received the MacArthur Fellowship and he was elected to become Corresponding Member of the Austrian Academy of Sciences, Fellow of the American Association for the Advancement of Science, the American Academy of Arts and Sciences, and the National Academy of Sciences.



Yuquan Wei

State Key Laboratory of Biotherapy and Clinical Cancer Center, West China Hospital, Sichuan University, China Ph.D., Professor and Director of National/State Key Laboratory of Biotherapy and Clinical Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, academician of Chinese Academy of Sciences. He was educated at West China University of Medical Sciences for a bachelor's degree in Medicine and a Master's Degree in Medicine, and educated at Kyoto University in Japan for a Doctoral Degree. His major research interests include targeted therapy, signal transduction, gene and cell therapy, and cancer vaccines. He has published more than 300 papers in international journals including Nature, Nat Med, Nat Commun, PNAS, Blood, Cancer Res, Clinic Cancer Res, J Immunol, and J Biol Chem, etc. He is now President of China Medicinal Biotech Association. He has served as the cheif editor of Signal Transduction and Targeted Therapy, an associate editor of Human Gene Therapy and Editorial Board Member of several International Journals.

Last page：MedComm - Plasma therapy cured a COVID‐19 patient with long duration of viral shedding for 49 days Next page：Molecular Biomedicine Introduction